Mild hyperhomocysteinaemia is associated with increased risk for vascular disease. We studied homocysteine export from human umbilical vein endothelial cells (HUVECs) by measuring total homo cysteine (tHcy) concentrations in the culture medium. Under standard culture conditions tHcy concentra tions in the HUVEC culture medium increased by constant amounts after 24, 48 and 72 h [mean = 2*5 (SD ± 0-7) ¡in10I L " 1 homocysteine every 24 h]. As the cells are the only source of homocysteine increase in the culture medium, we designate this as homocysteine export from HUVEC. Folic acid supplementation to the culture medium lowered the homocysteine export in a dose-dependent manner. Methyl-tetrahydrofolate (MeTHF) and folinic acid (a stable precursor of MeTHF) were in this respect about 10 times more effective than folic acid. A 50% reduction in the homocysteine export was seen with 10-30 nmol L 1 MeTHF supplementation; reduction to almost zero was seen with 100-300 nmol L " 1 MeTHF. Additions to the culture medium of the other vitamins involved in the homocysteine metabolism, such as vitamin B i2, vitamin B6 and flavin adenine dinucleotide, did not show any effect on homocysteine export. Because homocysteine export reflects an imbalance in the homocysteine metabolism, our observations showed a susceptible dependency of this metabolism on folic acid in endothelial cells.
Introduction
Severe hyperhomocysteinaemia (homocystinuria) is in most cases caused by an autosomal recessive inherited deficiency of cystathionine synthase (CS) or methylenetetrahydrofolate reductase (M T H FR) [1] . Clinic ally the most life-threatening complication of CS and M T H F R deficiency is severe arteriosclerosis or thrombosis [2, 3] . Mild hyperhomocysteinaemia is Correspondence: E. F. van der Molen, Department of Paedi atrics, University Hospital Nijmegen, PO Box 9101, 6500 HB Nijmegen, the Netherlands. associated with the development of arteriosclerosis [4 6] and obstetric complications [7 9j . M ild hyper homocysteinaemia can theoretically be caused by reduced activities of CS, methionine synthase (MS) or M T H FR or by deficiencies of folic acid and vitamin Bp, Recently, a common mutation in the I w v M TH FR gene causing reduced enzymatic activity has been described as one of the causes of mild hyperhomocysteinaemia [10] ( Fig. D . The treatment of hyperhomocysteinaemia (mild or severe) involves administration o f pyridoxine, folic acid, vitamin B^ or hetaine [11|, In particular, admini stration of folic acid results in a strong decrease in plasma tHcy concentration in mild hyperhomoeysteinaemia and the combination of folic acid and pyridoxine normalizes mild hyperhomocysteinaemia in virtually all cases [12 14 ].
In vitro high levels of homocysteine can generate
HiO-> and the vasotoxic properties of homocysteine through lipid peroxidation have been proposed [15] . However, in plasma from patients with severe hyper homocysteinaemia no increase in lipid peroxidation could be found [16, 17] , Several in vitro studies with endothelial cells have shown cell dysfunction when homocysteine is added to the medium. Lentz & Sadler [IK] showed that homocysteine reduced the thrombo modulin and von Willebrand factor excretion of HUVECs (human umbilical vein endothelial cells), Also, direct inactivation of protein C by homocysteine has been reported [19] . According to Nishinaga et ai [20] homocysteine reduces the expression of heparan sulphate on the cell membrane, and Hajjar [21] showed that the number of binding sites for tissue plasminogen activator (tPA) on the cell membrane may be reduced hv homocysteine. However, the abovementioned studies used very high concentrations ol homocysteine in its reduced form (i,e. with free SH groups). This is extremely non-physiological because only 1% of homocysteine is present in blood in its reduced form. A dose of 10 mmol L 1 reduced homo cysteine in vitro is about 50 000 times higher than the amount of reduced homocysteine present in the blood of patients with mild hyperhomocysteinaemia
Little is known about the homocysteine metabolism in endothelial cells. Recent studies with lymphoma cells and fibroblasts described homocysteine export into the extracellular medium [23] [24] [25] . The homo cysteine export seemed to be dependent on cell pro liferation and additions to the culture medium of inhibitors of homocysteine metabolism. It was concluded that homocysteine export reflected an imbalance in homocysteine production and metabolism [11] .
In the present paper homocysteine export was studied in human umbilical vein endothelial cells (HUVECs), including the effects of additions to the culture medium of vitamins involved in homocysteine metabolism.
Materials and methods

Cell culture
Endothelial cells from the human umbilical vein (HUVEC) were obtained from umbilical cords of healthy fetuses from uncomplicated pregnancies and deliveries of healthy mothers (non-smoking and with out medication). The cord was collected in buffer solution [4 mmol KC1, 140 mmol L -1 NaCl, 10 mmol L " 1 HEPES, llm m o lL 1 D-glucose H 20 (Merck, Germany), 105IU of penicillin and 105 IU of streptomycin (Boeringer Mannheim, Germany) with pH 7-3.] W ithin 24 h after cord collection endothelial cells were isolated by collagenase (Worthington, N J, USA) treatment according to the procedure of JafTe et aL [26] . The endothelial cells were seeded in two wells of a six-well plate, 10 cm2 each (all tissue culture plastics used were from Costar, Cam bridge, M A, USA) coated with human cryoprecipitate (local bloodbank) and cultured in M l 99 (Flow laboratories, Irving, UK) supplemented with 20 mmol L" 1 Hepes (Merck, Germany), 10% human serum (local blood bank), 10% newborn calf serum (Gibco, Grand Island, N Y, USA), 1% 200 mmol L/ " 1 L-glutamine (Flow ICN , USA), 5 IU m L~l heparin (stock from our own pharmacy) and 150/^gmL" 1 crude preparation of endothelial cell growth factor (Macaig el aL [27] ) and incubated in 5% C 0 2 and 95% air at 37 °C, When cells reached confluence, they were detached by trypsin/EDTA sodium salt (Flow IC N , USA) (50 mg/25 mg) diluted in 100 mL of a solution of 136-9 mmol L _1 NaCl, 5*4 mmol L "'1 KC1, 4-2 mmol L_ IN aH C 0 3 , 5 m m o lL " 1 D-glucose and 0*002% phenol red and seeded in the completely coated sixwell plate (split ratio of 1:3). The medium was (O 1996 Blackwell Science Ltd, European Journal o f Clinical Investigation, 26 , 304-309 306 E. F. VAN DER MOLEN et al renewed every 2 or 3 days. All HUVEC experiments were performed with 3-day confluent cells from the second passage in six-well plates. The standard culture medium was removed and the test medium was applied, then, after incubations of 24, 48 or 72 h, the test medium was collected in separate ampoules and stored at -20°C for further analyses. After removal of the test medium the cells were trypsinized, counted by using the counter chamber (haemocytometer) and checked for viability with trypan blue. All experi ments were performed with at least three different HUVEC lines.
Homocysteine analysis
Total homocysteine (tHcy) concentrations were measured by an automated high-performance liquid chromatography (HPLC) method with reverse-phase separation and fluorescent detection (Gilson 232-401 sample processor, Spectra Physics 8800 solvent delivery system and Spectra Physics LC 304 fluorimeter) essentially according to Fiskerstrand et aL [28] with some modifications (te Poele-Pothoff et aL [29] ) the detection limit was 0*5 ¿¿mol L " 1. The intra-and inter run variation coefficient was <5%. The tHcy analysis involved reduction of all disulphide bounds by sodium borohydride (Sigma, USA). After derivatization by monobromobimane (Sigma) the homocysteinemonobromobimane complex was separated by using reverse-phase HPLC.
In a small experiment, reduced homocysteine (with free SH groups) was added to the culture medium, the amount of reduced homocysteine in the culture medium was measured by binding free SH groups with DTNB [5,5'-dithiobis-(-nitrobenzoate) or Ellmans's reagent]. The solution consisted of 0* 1 mmol L~1 DTNB, 0-1 mol L~! Tris, 0*3m m olL"1 acetyl CoA and 0*5mmol L~1 oxaloacetate and absorption was measured at 412 nm [30] .
Vitamin!methionine analysis
Vitamin Bl2 and total folic acid concentrations in medium and serum were measured simultaneously with Dualcount (solid-phase boil) SPB radioassay (Diagnostic Products Corporation, Los Angeles, CA, USA) as described previously [31] . According to the manufacturer (Flow Laboratories, Irving, UK), M l99 contained 22*7 nmolL~l (0*01 mgL~!) folic acid. The total folic acid concentration in serum varied from 16*1 to 31-6 nmol L-1, therefore the concentration of total folic acid in the standard culture medium could be calculated to be 21-4-24*5 nmol L" 1. Measure ments of the total folic acid concentration in the culture medium showed a concentration of 26 nmol L" 1. Methionine concentrations were determined using ion-exchange chromatography on an amino acid analyser (Biotronik LC 6001) according to the manufacturer's instructions.
Added chemicals
Folic acid, 5-methyltetrahydrofolate (MeTHF), pyridoxakvphosphate (PLP), methylcobalamin (Mecobalamin), flavin adenine dinucleotide (FAD) and L-homocysteine thiolacton were obtained from Sigma. Hydroxocobalamin and folinic acid (leucovorin) were obtained from Byk Nederland, Stock solution (for direct use) of 0*3moiL 1 lhomoeysteine in its reduced form (with free SH groups) was obtained by incubation of L-honiocysteine thiolacton in 20(5/¿L of NaOH (5molL "1 ) at 40"C for 5min and thereafter neutralized with 400/¿L of phosphate buffer pH 7*8 (()• I mol L ') and 400 /¿L of HC1 (2*5 mol L •). Reduced pure r.-homocysteine is not commercially available.
Results
Homocysteine concentrations in culture medium * The mean concentration of tHcy in fresh culture medium before incubation of 23 different experi ments was 3'4/anolL 1 (range 3-0 4*3) and origi nated from the serum.
Addition of freshly prepared reduced homocysteine (i.e. with a free SH group) to the culture medium resulted in a rapid decline in the concentration of reduced homocysteine. The half-life of reduced homo cysteine in culture medium was 2 3 Ik Free SH groups are reactive and will be rapidly oxidized to disul phides, In human plasma only 1% of the total amount of homocysteine is present in the reduced form [11] . The half-life of reduced homocysteine was the same when no HUVECs or coating of human cryopreeipitatc was present and therefore the decline of reduced homocysteine was independent of cell exposure or coating. Incubation with 50 100/¿mol L 1 t.-homoeysteine for 24 h showed no efleet on HUVECs (visually and cell viability) when compared with cells incubated in standard medium (data not shown).
Homocysteine export, methionine and folic acid concentrations in endothelial cell culture medium
When cells were in the second passage and at least 3 days in monolayer under standard culture conditions, the cells exported a fairly constant amount of homo cysteine in the culture medium. Experiments with six different HUVEC lines showed similar results, with a mean homocysteine export after 24 h of 2*4 (SD ± 0*6) //molL between 24 and 48 h of 2-7 (SDdtO-9) /¿molL 1 and between 48 and 72 h of 2*3 (SD±0-7) //.mol L 1 (Fig. 2) ,
The concentration of methionine decreased from 80 to 69//mol L 1 in 72 h and the concentration of folic acid from 26 to 23 nmol L 1 in 72 h and the concen tration of vitamin BP from ISO to IftOpmolL 
Homocysteine, export and effects of vitamin addition
Folic acid. Supplementing the standard culture medium of HUVECs with folic acid reduced homo cysteine export in a dose-dependent manner. Addition of 300 nmol L~"J folic acid reduced homocysteine export by about 50%. When 3-10/xmolL" 1 folic acid was added, homocysteine export was almost zero. Experiments with two other cell lines showed similar results ( Table 1) . Addition of folic acid did not affect cell number or viability. 
MeTHF (nmol L r 1) Incubation times were 24, 48 and 72 h. The culture medium was supplemented with various concentrations of folic acid (0, 0*i, 0-3, 1,3 and 10/rniolL"1), MeTHF (0, 10, 30, 100, 1000 nmol L" 1) and folinic acid (0 , 10, 30, 100, 1000 nmol L" 1)* MeTHF and folinic acid. Medium M199 contained only folic acid (i.e. its oxidized form). The serum also contributed to the folic acid level of the standard culture medium (see Materials and methods). Because MeTHF is the main circulating form of folic acid in the body, we considered in our calculations the amount of folic acid in serum as MeTHF. There fore, the baseline concentration of MeTHF in the standard culture medium was considered to be 4*7 nmol L"1. Addition of various concentrations of MeTHF or folinic acid (the more stable precursor of MeTHF) to the culture medium reduced homo cysteine export in a dose-dependent manner, A typi cal presentation of this dose dependency is shown in Fig. 3 . The concentrations of MeTHF or folinic acid were about 10 times lower than that of folic acid required to observe similar homocysteine export reduction (Table 1) , Homocysteine export was reduced by 50% by addition of 10-30 nmol L-1 MeTHF or folinic acid, and addition of 100-300 nmol L~l resulted in almost zero homocysteine export (Table  1 ). Experiments with two other cell lines showed similar results, Folinic acid seems to be more effective in reducing the homocysteine export than MeTHF, although MeTHF is the direct substrate in the remethylation of homocysteine in methionine.
Hydroxocobalamin/Me-cobalamin, PLP and FAD.
Me-cobalamin (active form of vitamin B I2) is a cofactor of methionine synthase in the remethylation of homocysteine to methionine. Medium M l 99 con tained no vitamin B12. The concentration of vitamin Bl2 in the culture medium was (due to its presence in serum) 180 pmol L""1. Addition of extra vitamin B12 to the culture medium either in the form of hydroxo cobalamin or Me-cobalamine had no effect on the homocysteine export ( Table 2) .
PLP (active form of vitamin B6) is the co-factor of cystathionine /3-synthase (CS), which catalyses the
HOMOCYSTEINE METABOLISM IN HUVEC 307
Time (h) Incubation times were 24, 48 and 72 h. The culture medium was supplemented with various concentrations of Me-cobalamin (0, I, 10-, 104 nm olL"1), PLP (0, 10, 100/¿mo! L~') and FAD (0, 120, 300, 7 50 nmol L" 1). conversion of homocysteine in cystathionine. Stan dard culture medium contained 2*2 jimol L ~1 (0*05 mg L " 1) vitamin B6. Addition of PLP did not reduce the homocysteine export (Table 2) . F A D is a co-factor of M T H FR in the formation of M eTHF from methylene-THF. Standard culture medium contained 0-01 m g L " 1 riboflavin (stable pre cursor of FAD), and the addition of FA D to the culture medium did not affect homocysteine export ( Table 2 ). In all experiments the cell number and the cell viability were not influenced by the additions of these vitamins.
Discussion
HUVECs exported homocysteine at a virtually con stant rate over 72 h under standard culture conditions (Fig. 2) . This effect was highly reproducible in six different HU VEC lines. The cell number and cell viability remained unchanged and the concentrations in the culture medium of methionine, vitamin B12 and total folic acid decreased only slightly over 72 h.
Addition of folic acid to the medium reduced homocysteine export in a dose-dependent manner. MeTHF is the main circulating form of folic acid in blood and is a direct substrate in homocysteine remethylation. MeTHF also reduced homocysteine export in a dose-dependent manner, at a 10 times lower concentration than folic acid (Table 1) . Folinic acid, a more stable one-carbon THF precursor of MeTHF, showed similar results. In addition, folinic acid had a greater tendency to reduce homocysteine export than MeTHF, probably because of its higher stability.
In our hospital, normal folate levels in human plasma are considered to be between 7 and 30 nmol L l . Extrapolating to the in vitro situation this means that endothelial cells are exporting a fair amount of homocysteine in the presence of normal folate levels. Even after addition of 10 30 nmol L 1 MeTHF, the main form of folate in blood, a homocysteine export of 50% of the initial value was still observed.
Additions of other vitamins involved in hom o cysteine metabolism, such as Me-cobalamin, PLP and FAD, had no effect on homocysteine export [32] , An explanation is that these compounds are cofactors of the enzymes of homocysteine metabolism, whereas MeTHF is a substrate o f homocysteine remethylation.
Refsum et aL [23] and Christensen et aL [24, 25] studied homocysteine export in murine lymphoma cells, rat liver cells and in human fibroblasts, but not in human endothelial cells. In the celt homocysteine is either converted to cysteine or salvaged to methionine through remethylation or exported from the intracel lular compartment into the extracellular medium. Ueland et aL [11] concluded that homocysteine export reflects an imbalance between homocysteine production and metabolism. In this study with HUVECs, the imbalance in homocysteine metabol-1 * ism, as reflected by the high homocysteine export, disappeared after addition of folates to the medium.
In the human body the concentration of homocyst eine in plasma is probably dependent on cellular homocysteine export and on the capacity for homo cysteine degradation, mainly in liver and kidney [33] . Dysfunction of each of these systems can theoretically cause hyperhomocysteinaemia [l,2|. The observed imbalance in the homocysteine metabolism in cul tured endothelial cells may reflect the in vitro situw ation but, on the other hand, it mav reflect a natural feature of endothelial cells that can contribute to the vulnerability of endothelial cells to mild hyperhomo cysteinaemia, C ertain conditions are likely to enhance homocysteine export, such as disruption of the endo thelial cell layer (resulting in repair, thus enhanced cell proliferation) or of the composition of the extracel lular fluid (shortage of vitamins, higher levels of methionine or administration of certain drugs such as methotrexate).
Homocysteine-lowering therapy in patients with severe hyperhomocysteinaemia has proved to be clinically beneficial [3] . In mild hyperhomocystein aemia, such clinical effects remain to be determined. Folic acid regiments are very effective in lowering plasma homocysteine levels in vivo [12, 13] . In this study, folic acid proved to he very effective in main taining low homocysteine levels in the culture medium, probably as a result of the restored balance of the homocysteine metabolism in the cultured endothelial cells.
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